The health system will study the use of SparkRx, an evidence-based program sent to individuals via smartphones, that can help treat symptoms of depression in specialty medical care settings, according to a Sept. 6 press release.
Specifically, Children’s Hospital of Los Angeles will evaluate how SparkRx performs in adolescent patients being treated in its cardiology and gastroenterology programs that have elevated depressive symptoms.
“We’re excited about this opportunity to offer our patients a new resource for adolescent depression via a digital therapeutic that could help minimize barriers and increase access to mental health treatment,” said Heather Bemis, Ph.D, licensed clinical psychologist at Children’s Hospital of Los Angeles and principal investigator of the study.
The aim of the study is to understand if the study participants find SparkRx to be a convenient treatment option, if it can reduce the symptoms of depression in adolescents with chronic medical conditions and to collect feedback on the participants’ experience using SparkRx.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
